Sipai Health Technology Co. Ltd. (0314:HK) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the Sipai Health Technology Co. Ltd. stock forecast from 0 analysts, the average analyst target price for Sipai Health Technology Co. Ltd. is not available over the next 12 months. Sipai Health Technology Co. Ltd.’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Sipai Health Technology Co. Ltd. is Bearish, which is based on 1 positive signals and 4 negative signals. At the last closing, Sipai Health Technology Co. Ltd.’s stock price was HKD 5.90. Sipai Health Technology Co. Ltd.’s stock price has changed by +0.51% over the past week, -2.48% over the past month and -85.90% over the last year.
No recent analyst target price found for Sipai Health Technology Co. Ltd.
No recent average analyst rating found for Sipai Health Technology Co. Ltd.
Company Overview Sipai Health Technology Co. Ltd.
Sipai Health Technology Co., Ltd. operates as a medical technology and health management company in the People's Republic of China. The company operates through three segments: Specialty Pharmacy Business, Physician Research Assistance Business, and Health Insurance Services Business. The Specialty Pharmacy Business segment operates specialty pharmacy stores; and distributes pharmaceutical products to pharmaceutical companies and other distributors. The Physician Research Assistance Business segment offers pharmaceutical companies and other clinical trial institutions site management organization services, including site feasibility, site initiation, patient recruitment, patient management, data entry and document management, on-site drug management and bio-sample management, site closure, and others; and services for image management in clinical trials. The Health Insurance Services Business segment provides insurance brokerage services to insurance companies. The company was founded in 2014 and is headquartered in Guangzhou, the People's Republic of China. Address: Units 11-13, Tower A, Guangzhou, China Read Less
Sipai Health Technology Co., Ltd. operates as a medical technology and health management company in the People's Republic of China. The company operates through three segments: Specialty Pharmacy Business, Physician Research Assistance Business, and Health Insurance Services Busi...Read More
N/A
N/A
3,082
December
HKD
Hong Kong
Adjusted Closing Price for Sipai Health Technology Co. Ltd. (0314:HK)
Loading...
Unadjusted Closing Price for Sipai Health Technology Co. Ltd. (0314:HK)
Loading...
Share Trading Volume for Sipai Health Technology Co. Ltd. Shares
Loading...
Compare Performance of Sipai Health Technology Co. Ltd. Shares
Symbol
Capital Gain
Dividend Return
Total Return
Loading...
Loading...
Technical Indicators for 0314:HK
Assets
Top Holdings
N/A
Top Sectors
Top Regions
Stocks Similar To Sipai Health Technology Co. Ltd. (Sector: Medical Distribution )
Frequently Asked Questions About Sipai Health Technology Co. Ltd. (0314:HK) Stock
Stock Target Advisor's fundamental analysis for Sipai Health Technology Co. Ltd.'s stock is Bearish.
Unfortunately we do not have enough data on 0314:HK's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 0314:HK's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on 0314:HK's stock to indicate if its overvalued.
The last closing price of 0314:HK's stock was HKD 5.90.
The most recent market capitalization for 0314:HK is HKD 4.49B.
Unfortunately we do not have enough analyst data on 0314:HK's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Sipai Health Technology Co. Ltd.'s stock.
As per our most recent records Sipai Health Technology Co. Ltd. has 3,082 Employees.
Sorry we do not have any infomation available on Sipai Health Technology Co. Ltd.'s address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 0314:HK !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
